Entact Bio: Ledger

Stories naming Entact Bio. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Entact Bio is not recorded as having acquired anything.

Name	Role	Sources
Victoria Richon	CEO	Brandon Capital portfolio

Series A $81m

Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement

Biotech startup Entact Bio has launched with an $81 million Series A funding its Encompass platform, which designs molecules that enhance protein function, backed by Qiming Venture Partners USA, venBio Partners and others.

Brandon Capital portfolio 6 Dec 2022 Entact Bio Citadel Dana-Farber Cancer Institute Harvard Medical School Sheppard R&D Consultancy Ltd.University of Liverpool Abingworth Brandon Capital WEHI David Komander David Sheppard Jarrod Marto Michael Clague Sara Buhrlage Sylvie Urbé Ueli Nachbur Victoria Richon

Entact Bio

Funding history

Investors

What Entact Bio bought

People

Coverage

Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement